Supporting Intent Page

Nifty Pharma Valuation: Cheap, Fair, or Expensive?

A data-driven valuation view for Nifty Pharma using current and historical index metrics.

Updated: 05 Jun 2026 | Data as of: 05 Jun 2026 | Path: /indices/pharma/valuation

Index Value
24,248.05
Daily Change
0.00%
PE
37.06
PB
5.18
Dividend Yield
0.75%
Snapshot Date
05 Jun 2026

Valuation Zone

Zone is Fair based on historical PE context. Method: percentile.

FairPercentile meter
Valuation Zone
Fair
Current PE
37.06
Current PB
5.18
PE 5Y Avg
33.77
PE 10Y Avg
36.85
Dividend Yield
0.75%
SIP
Continue

Continue SIP steadily.

Lump-sum
Wait

Prefer staggered entries and avoid rushing.

Rules-based educational guidance only. Not a buy/sell call.

Historical Market Crashes: PE & PB Context

How does Nifty Pharma today compare with major market crashes? This table shows PE and PB at crash peaks and troughs to give historical context.

EventPeriodPeak PETrough PEPeak PBTrough PBDrawdown
🦠2020 COVID CrashJan 2020 → Mar 202026.5319.873.252.46-22.2%
📊 CurrentToday37.065.18

Peak and trough dates are approximate based on available index data. Drawdown shows the price decline from peak to trough.